Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1941 1
1942 1
1945 1
1946 2
1947 2
1948 4
1949 2
1950 3
1951 1
1952 2
1953 1
1954 2
1955 1
1957 3
1958 2
1959 3
1960 6
1961 4
1962 6
1963 5
1964 3
1965 6
1966 10
1967 5
1968 12
1969 8
1970 14
1971 11
1972 6
1973 11
1974 3
1975 6
1976 10
1977 10
1978 6
1979 11
1980 7
1981 7
1982 8
1983 24
1984 7
1985 4
1986 8
1987 7
1988 7
1989 16
1990 17
1991 8
1992 7
1993 9
1994 11
1995 11
1996 9
1997 11
1998 19
1999 32
2000 24
2001 34
2002 43
2003 26
2004 35
2005 26
2006 28
2007 27
2008 22
2009 27
2010 34
2011 28
2012 33
2013 39
2014 26
2015 31
2016 31
2017 30
2018 41
2019 38
2020 32
2021 41
2022 28
2023 32
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

1,102 results

Results by year

Filters applied: . Clear all
Page 1
The rapid spread of carbapenem-resistant Enterobacteriaceae.
Potter RF, D'Souza AW, Dantas G. Potter RF, et al. Drug Resist Updat. 2016 Nov;29:30-46. doi: 10.1016/j.drup.2016.09.002. Epub 2016 Sep 19. Drug Resist Updat. 2016. PMID: 27912842 Free PMC article. Review.
The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies.
Pötter R, Tanderup K, Kirisits C, de Leeuw A, Kirchheiner K, Nout R, Tan LT, Haie-Meder C, Mahantshetty U, Segedin B, Hoskin P, Bruheim K, Rai B, Huang F, Van Limbergen E, Schmid M, Nesvacil N, Sturdza A, Fokdal L, Jensen NBK, Georg D, Assenholt M, Seppenwoolde Y, Nomden C, Fortin I, Chopra S, van der Heide U, Rumpold T, Lindegaard JC, Jürgenliemk-Schulz I; EMBRACE Collaborative Group. Pötter R, et al. Clin Transl Radiat Oncol. 2018 Jan 11;9:48-60. doi: 10.1016/j.ctro.2018.01.001. eCollection 2018 Feb. Clin Transl Radiat Oncol. 2018. PMID: 29594251 Free PMC article. Review.
Adolescent and adult differences in major depression symptom profiles.
Rice F, Riglin L, Lomax T, Souter E, Potter R, Smith DJ, Thapar AK, Thapar A. Rice F, et al. Among authors: potter r. J Affect Disord. 2019 Jan 15;243:175-181. doi: 10.1016/j.jad.2018.09.015. Epub 2018 Sep 11. J Affect Disord. 2019. PMID: 30243197 Free article.
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study.
Pötter R, Tanderup K, Schmid MP, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Ristl R, Petric P, Nesvacil N, Kirchheiner K, Kirisits C, Lindegaard JC; EMBRACE Collaborative Group. Pötter R, et al. Lancet Oncol. 2021 Apr;22(4):538-547. doi: 10.1016/S1470-2045(20)30753-1. Lancet Oncol. 2021. PMID: 33794207 Clinical Trial.
Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial.
Mendell JR, Sahenk Z, Lehman K, Nease C, Lowes LP, Miller NF, Iammarino MA, Alfano LN, Nicholl A, Al-Zaidy S, Lewis S, Church K, Shell R, Cripe LH, Potter RA, Griffin DA, Pozsgai E, Dugar A, Hogan M, Rodino-Klapac LR. Mendell JR, et al. Among authors: potter ra. JAMA Neurol. 2020 Sep 1;77(9):1122-1131. doi: 10.1001/jamaneurol.2020.1484. JAMA Neurol. 2020. PMID: 32539076 Free PMC article. Clinical Trial.
Delandistrogene Moxeparvovec Gene Therapy in Ambulatory Patients (Aged ≥4 to <8 Years) with Duchenne Muscular Dystrophy: 1-Year Interim Results from Study SRP-9001-103 (ENDEAVOR).
Zaidman CM, Proud CM, McDonald CM, Lehman KJ, Goedeker NL, Mason S, Murphy AP, Guridi M, Wang S, Reid C, Darton E, Wandel C, Lewis S, Malhotra J, Griffin DA, Potter RA, Rodino-Klapac LR, Mendell JR. Zaidman CM, et al. Among authors: potter ra. Ann Neurol. 2023 Nov;94(5):955-968. doi: 10.1002/ana.26755. Epub 2023 Sep 7. Ann Neurol. 2023. PMID: 37539981
Haemangioblastomatosis.
Gillardin P, Lemmerling M, Bouttens F, Colle H, De Potter R, De Backer AI. Gillardin P, et al. Among authors: de potter r. J Belg Soc Radiol. 2015 Sep 15;99(1):99-100. doi: 10.5334/jbr-btr.839. J Belg Soc Radiol. 2015. PMID: 30039081 Free PMC article. No abstract available.
Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV.
Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, Dumas I, Hellebust TP, Kirisits C, Lang S, Muschitz S, Nevinson J, Nulens A, Petrow P, Wachter-Gerstner N; Gynaecological (GYN) GEC-ESTRO Working Group. Haie-Meder C, et al. Among authors: potter r. Radiother Oncol. 2005 Mar;74(3):235-45. doi: 10.1016/j.radonc.2004.12.015. Radiother Oncol. 2005. PMID: 15763303 Review.
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study.
Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group. Schmid MP, et al. Among authors: potter r. J Clin Oncol. 2023 Apr 1;41(10):1933-1942. doi: 10.1200/JCO.22.01096. Epub 2023 Jan 4. J Clin Oncol. 2023. PMID: 36599120
1,102 results